Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8+ T cell immunity in CLL and MDS patients

Susana Patricia Amaya Hernandez, Ditte Stampe Hersby, Kamilla Kjærgaard Munk, Tripti Tamhane, Darya Trubach, Maria Tagliamonte, Luigi Buonaguro, Anne Ortved Gang, Sine Reker Hadrup, Sunil Kumar Saini*

*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

44 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8+ T cell immunity in CLL and MDS patients'. Together they form a unique fingerprint.

Immunology and Microbiology

Keyphrases

Medicine and Dentistry